Suffolk Opens $50 Million AI and Robotics Hub at Its Roxbury Headquarters
Suffolk 100MAG: the Boston builder opened a $50 million, 40,000-square-foot AI and robotics center at its Roxbury campus. What it does and why.
Boston business
Boston and Massachusetts business news: companies, deals, layoffs, startups, real estate and jobs.
Entegris Posts Record $1 Billion Quarter as Chip Demand Lifts Billerica Supplier
Entegris Q3 earnings: Billerica chip-materials supplier posts record $1.006B in sales, up 25%, EPS more than doubles. Charts, segments and Q4 outlook.
Alnylam Q3 Sales Jump 52% to $1.29 Billion on Amvuttra Heart Drug Demand
Alnylam Q3 earnings: product sales rose 52% to $1.29B as Amvuttra hit $1.13B. Charts on revenue, the $1.9B tax benefit, guidance and pipeline.
Flagship Merges Cellarity, Etiome and Empress Into AI Biotech Etcelera
Flagship Pioneering launches Etcelera, a Somerville AI drug discovery firm merging Cellarity, Etiome and Empress, which raised $374M before the deal.
Celtics Owners Give $200 Million to Boston Children’s, a Hospital Record
Boston Children’s Hospital gift: Celtics owners give $200M+, a hospital record, for a Brighton mental health campus, research, nurse training and more.
Biogen Q3 Revenue Jumps 11% to $2.8B as Apellis Drugs Offset MS Slide
Biogen Q3 2026 earnings: revenue rose 11% to $2.8B, beating forecasts, as Apellis drugs, Spinraza and Leqembi offset MS declines. Guidance edged up.
MGH, Brigham Sue Eli Lilly Over 340B Drug Discount Data Demands
Eli Lilly 340B lawsuit: MGH, Brigham and three other Massachusetts hospitals say Lilly cut drug discounts after they refused to share patient claims data.
Boston Earnings Q3 2026: State Street, American Tower, BXP Report; Vertex, Wayfair, Toast Next
Boston company earnings for Q3 2026: State Street, American Tower and BXP grew profits and raised outlooks, while Vertex, Toast, Wayfair and DraftKings report next.
Framingham’s Re:Build Raises $2.1 Billion to Expand U.S. Factories
Re:Build Manufacturing funding: the Framingham firm raised $2.1B led by General Catalyst and JPMorganChase to grow factories, buy firms, launch startups.
Boston Scientific Q3 Sales Rise 1.5% as Cyberattack Costs $150M, Shares Fall
Boston Scientific Q3 2026 earnings: sales rose 1.5% to $5.14B as the August cyberattack cost about $150M. Q4 sales seen down 1% to 3%; 2027 a trough.